Involvement of Adenosine A1 and A2A Receptors in the Adenosinergic Modulation of the Discriminative-Stimulus Effects of Cocaine and Methamphetamine in Rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 977-986

  Justinova, Zuzana ^a   Ferré, Sergi ^a   Segal, Pavan N ^a   Antoniou, Katerina ^b   Solinas, Marcello ^a   Pappas, Lara A ^a   Highkin, Jena L ^a   Hockemeyer, Jörg ^c   Munzar, Patrik ^a,d   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF BONN   (Germany)

^d Alexza Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 (3 HYDROXYPROPYL) 8 (3 METHOXYSTYRYL) 7 METHYL 1 PROPARGYLXANTHIN PHOSPHATE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR AFFECTING AGENT; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; COCAINE; METHAMPHETAMINE; MSX 3; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG SELECTIVITY; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0345599267     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.056762     Document Type: Article

References (40)

1. Baker LE, Riddle EE, Saunders RB, and Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79.
2. Baumgold J, Nikodijevic O, and Jacobson KA (1992) Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol 43:889-894.
3. Caine SB, Negus SS, Mello NK, and Bergman J (2000) Effects of dopamine D1-like and D2-agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol 8:404-414.
4. Cohen BE, Lee G, Jacobson KA, Kim YC, Huang Z, Sorscher EJ, and Pollard HB (1997) 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator. Biochemistry 36:6455-6461.
5. Colpaert FC (1986) Drug discrimination: behavioral, pharmacological and molecular mechanisms of discriminative drug effects, in Behavioral Analysis Of Drug Dependence (Goldberg SR and Stolerman IP eds) pp 161-193, Academic Press, Orlando.
6. Cunha RA, Johansson B, Constantino MD, Sebastiao AM, and Fredholm BB (1996) Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn-Schmiedeberg's Arch Pharmacol 353:261-271.
7. Ferré S, Fredholm BB, Morelli M, Popoli P, and Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482-487.
8. Ferré S, Voneuler G, Johansson B, Fredholm BB, and Fuxe K (1991) Stimulation of high-affinity adenosine-A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88:7238-7241.
9. Fiorillo CD and Williams JT (2000) Selective inhibition by adenosine of mGluR IPSPs in dopamine neurons after cocaine treatment. J Neurophysiol 83:1307-1314.
10. Flagmeyer I, Haas HL, and Stevens DR (1997) Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Res 778:178-185.
11. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, et al. (2000) Dopamine D-1 and adenosine A(1) receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97:8606-8611.
12. Golembiowska K and Zylewska A (1997) Adenosine receptors-the role in modulation of dopamine and glutamate release in the rat striatum. Pol J Pharmacol 49:317-322.
13. Heffner TG, Wiley JN, Williams AE, Bruns RF, Coughenour LL, and Downs DA (1989) Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology (Berl) 98:31-37.
14. Herrera-Marschitz M, Luthman J, and Ferre S (1994) Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis. Psychopharmacology (Berl) 116:451-456.
15. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, et al. (2002) Coaggregation, cointernalization and codesensitization of adenosine A(2A) receptors and dopamine D-2 receptors. J Biol Chem 277:18091-18097.
16. Howell LL, Czoty PW, Kuhar MJ, and Carrol FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 292:521-529.
17. Jacobson KA, Guay-Broder C, van Galen PJ, Gallo-Rodriguez C, Melman N, Jacobson MA, Eidelman O, and Pollard HB (1995) Stimulation by alkylxanthines of chloride efllux in CFPAC-1 cells does not involve A1 adenosine receptors. Biochemistry 34:9088-9094.
18. Johannesson M, Bogdanovic N, Nordqvist AC, Hjelte L, and Schalling M (1997) Cystic fibrosis mRNA expression in rat brain: cerebral cortex and medial preoptic area. Neuroreport 8:535-539.
19. Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, Pezzola A, Reggio R, Muller CE, Fuxe K, et al. (2003) Involvement of adenosine A(1) and A(2A) receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28:1281-1291.
20. Knapp CM, Foye MM, Cottam N, Ciraulo DA, and Kornetsky C (2001) Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration. Pharmacol Biochem Behav 68:797-803.
21. Kuczenski R, Segal DS, Cho AK, and Melega W (1995) Hippocampus norepinephrine, caudate dopamine and serotonin and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-1317.
22. Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, and Butcher SP (1997) Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Br J Pharmacol 122:1202-1208.
23. Mori T, Narita M, Onodera K, and Suzuki T (2002) Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system. Nihon Shinkei Seishin Yakurigaku Zasshi 22:73-78.
24. Muller CE, Maurinsh J, and Sauer R (2000) Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes-a new, selective antagonist radioligand for A(2A) adenosine receptors. Eur J Pharm Sci 10:259-265.
25. Munzar P and Goldberg SR (1999) Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 143:293-301.
26. Munzar P and Goldberg SR (2000) Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 148:209-216.
27. Munzar P, Justinova Z, Kutkat SW, Ferré S, and Goldberg SR (2002a) Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 161:348-355.
28. Munzar P, Justinova Z, Kutkat SW, and Goldberg SR (2002b) Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine. Eur J Pharmacol 436:75-82.
29. Okada M, Mizuno K, and Kaneko S (1996) Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci Lett 212:53-56.
30. Poleszak E and Malec D (2000) Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats. Pol J Pharmacol 52:423-429.
31. Poleszak E and Malec D (2002) Adenosine receptor ligands and cocaine in conditioned place preference (CPP) test in rats. Pol J Pharmacol 54:119-126.
32. Popoli P, Pezzola A, and de Carolis AS (1994) Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats. Eur J Pharmacol 257:21-25.
33. Rimondini R, Ferre S, Ogren SO, and Fuxe K (1997) Adenosine A(2A) agonists: a potential new type of atypical antipsychotic. Neuropsychopharmacology 17:82-91.
34. Sasaki JE, Tatham TA, and Barrett JE (1995) The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology (Berl) 120:303-310.
35. Sauer R, Maurinsh J, Reith U, Fulle F, Klotz KN, and Muller CE (2000) Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists. J Med Chem 43:440-448.
36. Shimazoe T, Yoshimatsu A, Kawashimo A, and Watanabe S (2000) Roles of adenosine A(1) and A(2A) receptors in the expression and development of methamphetamine-induced sensitization. Eur J Pharmacol 388:249-254.
37. Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, and Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22:6321-6324.
38. Tidey JW and Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174.
39. Uhl GR, Hall FS, and Sora I (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7:21-26.
40. Yasar S, Schindler CW, Thorndike EB, and Goldberg SR (1994) Evaluation of deprenyl for cocaine-like discriminative stimulus effects in rats. Eur J Pharmacol 259:243-250.